Citadel Advisors’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
PCH
AIM
WA
Citadel Advisors's AXGN Position: Q2 2026 in Review
Citadel Advisors increased its Axogen (AXGN) stake by 455% in Q2 2026, buying an estimated $45M and bringing the position to 1,360,831 shares worth $62.9M. The position accounts for 0.01% of the portfolio, ranked #1349.
Citadel Advisors first reported a position in AXGN in Q2 2017 and has held it in 33 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.
- Citadel Advisors held 1,360,831 shares of Axogen worth $62.9M as of Q2 2026.
- Citadel Advisors bought 1,115,777 Axogen shares in Q2 2026, an estimated $45M.
- Axogen made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1349 holding.
- Citadel Advisors first reported a position in Axogen in Q2 2017 and has held it in 33 quarters since.
- 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.